SynthesisBMC pharmacology & toxicology2017

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Pravesh Kumar Bundhun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.